During the last session, Pasithea Therapeutics Corp (NASDAQ:KTTA)’s traded shares were 2.17 million, with the beta value of the company hitting 0.53. At the end
In today’s recent session, 182.88 million shares of the Pasithea Therapeutics Corp (NASDAQ:KTTA) have been traded, and its beta is 0.53. Most recently the company’s
During the last session, Pasithea Therapeutics Corp (NASDAQ:KTTA)’s traded shares were 0.11 million, with the beta value of the company hitting 0.49. At the end
In the last trading session, 1.66 million shares of the Pasithea Therapeutics Corp (NASDAQ:KTTA) were traded, and its beta was 0.37. Most recently the company’s
Pasithea Therapeutics Corp (NASDAQ:KTTA)’s traded shares stood at 101.15 million during the last session, with the company’s beta value hitting 0.62. At the close of
Pasithea Therapeutics Corp (NASDAQ:KTTA)’s traded shares stood at 87.08 million during the latest session, with the company’s beta value hitting 0.62. At the last check
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
